JAC Advance Access originally published online on June 20, 2006
Journal of Antimicrobial Chemotherapy 2006 58(3):706-707; doi:10.1093/jac/dkl269
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2006. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Correspondence |
In vitro antimycoplasmal activity of Melaleuca alternifolia essential oil
1 Department of Microbiological Sciences and Gynaecological Sciences, University of Catania Via Androne 81, 91524 Catania, Italy 2 Department of Pharmacobiological Sciences, University Magna Grecia of Catanzaro Viale Europa, I-88100 Catanzaro, Italy 3 Department of Pharmacobiology, University of Messina Viale Annunziata, 98100 Messina, Italy
*Corresponding author. Tel: +39-095316038; Fax: +39-095312798; E-mail: furneri@unict.it
Keywords: tea tree oil , TTO , Mycoplasma , susceptibility tests
| The first 10% of the full text of this article appears below. |
Sir,
The essential oil of Melaleuca alternifolia [i.e. tea tree oil (TTO)] has a long history of use as a topical antiseptic and has been used in Australia as an antiseptic since the 1920s. It is currently enjoying resurgent popularity and it is widely available in various formulations suitable for topical use.1
TTO has a wide spectrum of antimicrobial activity against Gram-positive and Gram-negative bacteria, both aerobic and anaerobic, against yeasts and fungi. It is also active against clinically isolated
Transparency declarations